Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound
06:00am, Thursday, 23'rd May 2024
Momentum trading is one of my favorite strategies. Legendary trader Mark Minervini, who won the U.S. investing championship in 1997 and 2021, used momentum trading strategies to win.
Is It Too Late to Buy Viking Therapeutics Stock?
08:15am, Wednesday, 22'nd May 2024
Viking Therapeutics stock is up by a significant amount this year. It still has key catalysts on the way that investors should note.
3 Growth Stocks That Could Be Millionaire-Makers: May Edition
02:36pm, Tuesday, 21'st May 2024
A lot of great stocks are flying under the radars of investors. There are plenty of lesser known stocks that are growing by leaps and bounds right now.
Wall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for May 2024
07:02am, Monday, 20'th May 2024
The Russell 2000 is a stock market index comprised of 2,000 companies that have small market capitalizations. A small-cap stock is generally any security of a publicly traded company whose market valu
3 Monster Stocks in the Making You Can Buy Right Now
06:47am, Saturday, 18'th May 2024
Altimmune could have a blockbuster weight-loss drug on the way. Axsome Therapeutics has two products on the market plus multiple promising-pipeline programs.
Pharma Stocks Outlook: Where Are 2024's Top Performers Headed Next?
03:02pm, Friday, 17'th May 2024
The three top performing stocks discussed below have appreciated in value by an average of 129.7% in 2024. Such torrid growth logically raises the question of what is possible moving forward.
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
11:06am, Friday, 17'th May 2024
Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this s
Is Viking Therapeutics Stock a Buy?
09:00am, Friday, 17'th May 2024
Viking's GLP-1 inhibitor candidate has shown promise for weight loss in clinical trials. But investors should keep in mind that the company has no approved products yet.
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
06:15am, Friday, 17'th May 2024
With innovation, millions of retiring baby boomers, demand for better care, patent cliffs, gene-editing, massive interest in weight-loss treatments, and an increase in mergers, biotech stocks to buy h
Tiny but Mighty: 3 Small-Cap Stocks Crushing the Russell 2000
07:00am, Thursday, 16'th May 2024
The mega-cap tech stocks have garnered much attention in recent months. However, certain smaller companies have also performed well, with some small-cap stocks to buy showing promise for growth.
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
12:41pm, Wednesday, 15'th May 2024
Viking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous potential. However, existing competition from obesity drugs in the market remains a woe.
Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025
07:08am, Tuesday, 14'th May 2024
If you're wondering what stocks to buy this month, look no further. Every investor wants their stock picks to double in price.
How Viking Therapeutics Stock Could 30x
10:00am, Monday, 13'th May 2024
Viking Therapeutics has been one of the hottest biopharma stocks in 2024. Even so, the market may be seriously underestimating the company's true value proposition.
Is Viking Therapeutics the Best Biotech Stock for You?
08:15am, Monday, 13'th May 2024
Viking has what could be a best-in-class asset for treating obesity. It also has some powerful competitors to face that have a strong lead.
What Makes Viking Therapeutics An Attractive Takeover Target Or Big Pharma Partner
05:43am, Sunday, 12'th May 2024
Viking Therapeutics' subcutaneously administered version of VK2735 has generated competitive data in the phase 2 trial in obese patients. The oral formulation of VK2735 reported good tolerability that
